Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aerosolized vancomycin therapy facilitating nursing home placement.

J D Gradon1, E H Wu, L I Lutwick

  • 1Division of Infectious Diseases, Maimonides Medical Center, Brooklyn.

The Annals of Pharmacotherapy
|February 1, 1992
PubMed
Summary

This study shows aerosolized vancomycin and nasal drops successfully eliminated methicillin-resistant Staphylococcus aureus (MRSA) in a hospitalized patient. This novel approach offers a potential solution for persistent MRSA colonization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Characteristics and predictors of postoperative outcome of Crohn disease patients requiring abdominal surgery: a series of 1 048 cases from a single inflammatory bowel disease centre].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2021
Same author

Pneumocystis carinii pneumonia in pregnancy.

Chest·2001
Same author

Current and future treatment of Lyme disease.

Expert opinion on pharmacotherapy·2001
Same author

The pitfalls of transthoracic echocardiography. A case of eustachian valve endocarditis.

Texas Heart Institute journal·2001
Same author

Brill-Zinsser disease.

Lancet (London, England)·2001
Same author

Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature.

Medicine·2001

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Medical Microbiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in healthcare settings, particularly for debilitated patients.
  • Nasopharyngeal colonization by MRSA is a risk factor for invasive infections and transmission within hospitals.
  • Conventional therapies often fail to eradicate persistent MRSA colonization, necessitating novel treatment strategies.

Observation:

  • A case study was conducted on a hospitalized patient with persistent nasopharyngeal MRSA colonization resistant to standard treatments.
  • The patient received a novel therapeutic regimen involving aerosolized vancomycin hydrochloride and vancomycin nasal drops.
  • This intervention was administered over four days to target MRSA in the nasopharyngeal region.

Findings:

Related Experiment Videos

  • The combined administration of aerosolized vancomycin and vancomycin nasal drops resulted in the successful elimination of MRSA from the patient's nasopharynx.
  • MRSA colonization was cleared within four days of initiating the novel therapeutic intervention.
  • The treatment was effective in a patient with previously recalcitrant MRSA colonization.

Implications:

  • Aerosolized vancomycin combined with nasal vancomycin drops presents a promising method for eradicating nasopharyngeal MRSA colonization.
  • This approach may be particularly beneficial for high-risk, hospitalized patients.
  • Further clinical trials are recommended to validate these findings and establish the efficacy and safety of this treatment regimen.